FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sigma-Tau Pharmaceuticals PEGASPARGASE ONCASPAR Injection Recall

PEGASPARGASE ONCASPAR Injection, 3750 International Units Per 5mL vial, Rx ONLY, sigma-…

Sigma-Tau Pharmaceuticals, Inc. · Gaithersburg, MD

Risk level
Class II
Reported by FDA
Jan 22, 2014
Recall ID
D-736-2014
Check your lot numberHow we source this data

Summary

Sigma-Tau Pharmaceuticals recalled PEGASPARGASE ONCASPAR Injection starting Nov 1, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-736-2014 on Jan 22, 2014. Reason: Lack of Assurance of Sterility: Sigma-Tau PharmaSource, Inc. is conducting a voluntary recall of five lots of Oncaspar Injection, because of a crack under the crimp seal which caused a leak. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Sigma-Tau PharmaSource, Inc. is conducting a voluntary recall of five lots of Oncaspar Injection, because of a crack under the crimp seal which caused a leak.

Product description

PEGASPARGASE ONCASPAR Injection, 3750 International Units Per 5mL vial, Rx ONLY, sigma-tau PHARMACEUTICALS INC, 9841 Washingtonian Blvd, Gaithersburg, MD 20878 NDC 54482-301-01

Lot numbers, UPCs & expiration codes

Lot# 3012A, 3013A, 30138, Exp. 11/13 Lot# 3014A, 3014A CLIN, Exp. 12/13

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-736-2014
Classification
Class II
Status
Terminated
Recall initiated
Nov 1, 2013
FDA report date
Jan 22, 2014
Quantity
7479 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Sigma-Tau Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-736-2014, exactly as published.

Show all FDA fields
City
Gaithersburg
State
MD
Status
Terminated
Country
United States
Event ID
66741
Address
9841 Washingtonian Blvd Ste 500
Code information
Lot# 3012A, 3013A, 30138, Exp. 11/13 Lot# 3014A, 3014A CLIN, Exp. 12/13
Postal code
20878-1978
Report date
Jan 22, 2014
Product type
Drugs
Recall number
D-736-2014
Classification
Class II
Recalling firm
Sigma-Tau Pharmaceuticals, Inc.
Product quantity
7479 vials
Termination date
Dec 18, 2014
Reason for recall
Lack of Assurance of Sterility: Sigma-Tau PharmaSource, Inc. is conducting a voluntary recall of five lots of Oncaspar Injection, because of a crack under the crimp seal which caused a leak.
Voluntary / mandated
Voluntary: Firm initiated
Product description
PEGASPARGASE ONCASPAR Injection, 3750 International Units Per 5mL vial, Rx ONLY, sigma-tau PHARMACEUTICALS INC, 9841 Washingtonian Blvd, Gaithersburg, MD 20878 NDC 54482-301-01
Distribution pattern
Nationwide
Recall initiation date
Nov 1, 2013
Initial firm notification
Telephone
Center classification date
Jan 15, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-736-2014, published Jan 22, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls